← Back to Search

Aquatic Exercise Program for Chronic Low Back Pain

N/A
Recruiting
Led By Maryse Fortin, PhD
Research Sponsored by Concordia University, Montreal
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Aged between 18 and 65 years old
Have a score of 'moderate' or 'severe' disability on the modified Oswestry Low Back Questionnaire
Must not have
Previous spinal surgery or vertebral fractures
Evidence of nerve root compression or reflex motor signs deficits
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 10-week
Awards & highlights
No Placebo-Only Group

Summary

This trial will compare effects of aquatic therapy & standard care on paraspinal & gluteal muscle size, composition & strength in people with chronic low back pain. Effects on pain, function & psychological factors will also be compared. Two 60-min sessions/week for 10 weeks.

Who is the study for?
This trial is for adults aged 18-65 with chronic low back pain who are currently seeking care and have moderate to severe disability according to a specific questionnaire. They should not be in lower back-specific training, have nerve root compression, previous spinal surgery, major spine abnormalities, or health conditions preventing exercise.
What is being tested?
The study compares aquatic therapy with standard care over a 10-week period to see which is better at improving muscle size and strength in the back and glutes, reducing pain, enhancing function and psychological well-being. Participants will attend two sessions per week.
What are the potential side effects?
Aquatic therapy may cause muscle soreness or fatigue initially as participants adjust to the exercises. Standard care side effects depend on the specific treatments used but could include similar discomfort from physical activities.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 65 years old.
Select...
My back pain is moderate to severe according to the Oswestry scale.
Select...
I am seeking treatment for lower back pain.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have had spinal surgery or vertebral fractures.
Select...
I have signs of nerve damage or compression.
Select...
I have significant spine issues not related to a common back problem.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 10-week
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 10-week for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in gluteal muscle size (cross-sectional area) in cm^2
Change in multifidus muscle size (cross-sectional area) in cm^2
Percent change in gluteal muscle fatty infiltration
+1 more
Secondary study objectives
Point score change in Insomnia Severity Index (ISI)
Point score change in Oswestry Low Back Pain Disability Index (ODI) score
Point score change in Tampa Scale of Kinesiophobia (TSK)
+5 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Standard CareExperimental Treatment1 Intervention
Standard care program including strengthening, flexibility, aerobic conditioning, modalities and manual mobilization techniques. Supervised 10-week program, 2 times a week.
Group II: Aquatic TherapyExperimental Treatment1 Intervention
Aquatic exercise program including trunk stabilization, upper body, lower body strengthening and flexibility exercises and aerobic conditioning. Supervised 10-week program, 2 times a week.

Find a Location

Who is running the clinical trial?

Concordia University, MontrealLead Sponsor
29 Previous Clinical Trials
5,221 Total Patients Enrolled
Maryse Fortin, PhDPrincipal InvestigatorConcordia University, Montreal

Media Library

Aquatic Therapy Clinical Trial Eligibility Overview. Trial Name: NCT05823857 — N/A
Muscle Wasting Research Study Groups: Aquatic Therapy, Standard Care
Muscle Wasting Clinical Trial 2023: Aquatic Therapy Highlights & Side Effects. Trial Name: NCT05823857 — N/A
Aquatic Therapy 2023 Treatment Timeline for Medical Study. Trial Name: NCT05823857 — N/A
~10 spots leftby Dec 2025